FDA Drug recall D-0605-2018
Flucanazole Injection, USP 200 mg in in 100 mL (2 mg/mL), 10 Single Dose Flexible Containers, Rx Only, Manufactured for: Claris Lifescience…
- FDA Drug
- Class III
- terminated
- Published 2018-04-04
On 2018-04-04 the FDA classified a Class III recall of Flucanazole Injection, USP 200 mg in in 100 mL (2 mg/mL), 10 Single Dose Flexible Containers, Rx Only, Manufactured for: Claris Lifescience… by Renaissance Lakewood, citing superpotent and Failed Stability Specifications; out of specification results for assay and water vapor permeability.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0605-2018 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2018-03-02 |
| Published | 2018-04-04 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Renaissance Lakewood |
| Distribution | US |
Product
Flucanazole Injection, USP 200 mg in in 100 mL (2 mg/mL), 10 Single Dose Flexible Containers, Rx Only, Manufactured for: Claris Lifesciences, Inc. North Brunswick, NJ 08902 By; Claris Injectables Ltd. Gujarat, India --- NDC 36000-006-10
Reason
Superpotent and Failed Stability Specifications; out of specification results for assay and water vapor permeability
Identifiers
| code_info | Lot A060644, May 2018 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0605-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.